Clinical trial
Addressing Cardiovascular Disease Multimorbidity in Patients Living With HIV in Nigeria
NCT07909395 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Addressing Cardiovascular Disease Multimorbidity in Patients Living With HIV in Nigeria
- Lead sponsor
- NYU Langone Health
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2027
- Completion date
- August 31, 2030
- Enrollment
- 1,050 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 3 arms.
-
R61 - Pilot PHCs
The HEARTS package will be pilot tested in 2 PHCs.
-
R33 - HEARTS Only
PHCs assigned to the standard care group, HEARTS only.
-
R33 - PF + HEARTS Package
PHCs assigned to the PF + HEARTS implementation group.
Primary endpoints
Registered primary outcome measures; 3 primary.
-
Implementation Fidelity of HEARTS at 12 Months
Fidelity is defined as the utilization of all components of the HEARTS program: identifying PLWH with uncontrolled hypertension (HTN) and diabetes mellitus (DM); measuring patient anthropometrics and BP; initiating lifestyle counseling and medication treatment every 1-3 months; and referring PLWH with complicated HTN and DM to physicians for further care.
-
Change in Systolic Blood Pressure (SBP) from Baseline to 12 Months
-
Change in Hemoglobin A1c (HbA1c) from Baseline to 12 Months
Lead sponsor's other trials
NYU Langone Health, most recent start first.
+1,425 more trials See the organization page
Similar trials
Same condition (Cardiovascular Diseases) and phase, most recent start first.
+2,119 more trials See the condition page